Last quarter (Q4 2023), Akebia Therapeutics's total revenue was $56.07M, an increase of 1.62% from the same quarter last year. In Q4, Akebia Therapeutics's net income was $-47.00K. See Akebia Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 180.49M	$ 194.62M	$ 292.60M	$ 213.58M	$ 295.31M	$ 335.00M
Cost of Revenue	$ 54.37M	$ 74.15M	$ 84.80M	$ -153.39M	$ 295.91M	$ 145.34M
Gross Profit	$ 148.97M	$ 120.47M	$ 207.81M	$ 213.58M	$ -601.00K	$ 189.66M
Operating Expense	$ 175.63M	$ 166.73M	$ 286.92M	$ -325.50M	$ 375.84M	$ 475.95M
Operating Income	$ -33.87M	$ -46.26M	$ -79.11M	$ -265.32M	$ -376.44M	$ -286.29M
Net Non Operating Interest Income Expense	$ -6.03M	$ -6.03M	$ -15.69M	$ -19.94M	$ -8.87M	$ 792.00K
Other Income Expense	$ -363.00K	$ -363.00K	$ -2.24M	$ -2.41M	$ 1.86M	$ -794.00K
Pretax Income	$ -42.59M	$ -51.92M	$ -92.56M	$ -282.84M	$ -383.46M	$ -286.29M
Tax Provision	-	-	-	-	$ 0.00	$ -6.63M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -51.92M	$ -51.92M	$ -86.21M	$ -282.84M	$ -383.46M	$ -279.66M
Basic EPS	$ -0.28	$ -0.28	$ -0.51	$ -1.70	$ -2.77	$ -2.36
Diluted EPS	$ -0.28	$ -0.28	$ -0.51	$ -1.70	$ -2.77	$ -2.36
Basic Average Shares	$ 749.86M	$ 187.47M	$ 182.78M	$ 165.95M	$ 138.46M	$ 118.40M
Diluted Average Shares	$ 749.86M	$ 187.47M	$ 182.78M	$ 165.95M	$ 138.46M	$ 118.40M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 230.00M	$ 240.88M	$ -371.72M	$ -478.90M	$ 671.75M	$ 621.29M
Net Income From Continuing And Discontinued Operation	$ -51.92M	$ -51.92M	$ -92.56M	$ -282.84M	$ -383.46M	$ -279.66M
Normalized Income	$ -30.04M	$ -40.22M	-	-	$ -383.46M	$ -279.66M
Interest Expense	-	-	-	-	-	-
EBIT	$ -42.59M	$ -51.92M	$ -92.56M	$ -282.84M	$ -376.44M	$ -286.29M
EBITDA	$ -7.19M	$ -16.53M	$ -54.87M	$ -244.88M	$ -342.85M	$ -247.64M

Currency in USD

Akebia Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing